These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 37181886

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S, Hausen A, Rauteenmaa T.
    J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.
    Stocker K, Hartmann M, Ley L, Becker AM, Holze F, Liechti ME.
    J Psychopharmacol; 2024 Jan; 38(1):80-100. PubMed ID: 37905369
    [Abstract] [Full Text] [Related]

  • 5. A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience.
    Neitzke-Spruill L, Glasser C.
    J Psychoactive Drugs; 2018 Jan; 50(4):314-321. PubMed ID: 30052496
    [Abstract] [Full Text] [Related]

  • 6. Psilocybin occasioned mystical-type experiences.
    James E, Robertshaw TL, Hoskins M, Sessa B.
    Hum Psychopharmacol; 2020 Sep; 35(5):e2742. PubMed ID: 32573835
    [Abstract] [Full Text] [Related]

  • 7. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.
    Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR.
    Front Psychol; 2017 Sep; 8():1238. PubMed ID: 28790944
    [Abstract] [Full Text] [Related]

  • 8. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M, Meester M.
    J Psychoactive Drugs; 2012 Sep; 44(5):410-7. PubMed ID: 23457892
    [Abstract] [Full Text] [Related]

  • 9. Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports.
    Žuljević MF, Mijatović A, Marušić SL, Kudrjavets G, Buljan I, Hren D.
    J Psychoactive Drugs; 2024 Sep; 56(5):657-669. PubMed ID: 37921118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.
    Fauvel B, Kangaslampi S, Strika-Bruneau L, Roméo B, Piolino P.
    J Psychoactive Drugs; 2023 Sep; 55(2):170-179. PubMed ID: 35384730
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Working with Weirdness: A Response to "Moving Past Mysticism in Psychedelic Science".
    Breeksema JJ, van Elk M.
    ACS Pharmacol Transl Sci; 2021 Aug 13; 4(4):1471-1474. PubMed ID: 34423279
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
    Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R.
    Front Pharmacol; 2021 Aug 13; 12():788155. PubMed ID: 35431912
    [Abstract] [Full Text] [Related]

  • 19. High dose psilocybin is associated with positive subjective effects in healthy volunteers.
    Nicholas CR, Henriquez KM, Gassman MC, Cooper KM, Muller D, Hetzel S, Brown RT, Cozzi NV, Thomas C, Hutson PR.
    J Psychopharmacol; 2018 Jul 13; 32(7):770-778. PubMed ID: 29945469
    [Abstract] [Full Text] [Related]

  • 20. Analysis of recreational psychedelic substance use experiences classified by substance.
    Hase A, Erdmann M, Limbach V, Hasler G.
    Psychopharmacology (Berl); 2022 Feb 13; 239(2):643-659. PubMed ID: 35031816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.